Compare, Analyse Sun Pharma with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs MYLAN (US) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   MYLAN
EQUITY SHARE DATA
    SUN PHARMA
Mar-19
MYLAN
Dec-18
SUN PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs6793,393-   
Low Rs3751,868-   
Sales per share (Unadj.) Rs121.11,561.2-  
Earnings per share (Unadj.) Rs13.442.4-  
Cash flow per share (Unadj.) Rs20.7334.7-  
Dividends per share (Unadj.) Rs2.750-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs172.61,689.0-  
Shares outstanding (eoy) m2,399.26514.50-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.41.7 258.3%   
Avg P/E ratio x39.462.0 63.5%  
P/CF ratio (eoy) x25.57.9 324.3%  
Price / Book Value ratio x3.11.6 196.1%  
Dividend payout %20.60-   
Avg Mkt Cap Rs m1,264,6501,353,254 93.5%   
No. of employees `00017.535.0 50.0%   
Total wages/salary Rs m59,6710-   
Avg. sales/employee Rs Th16,608.122,950.1 72.4%   
Avg. wages/employee Rs Th3,409.60-   
Avg. net profit/employee Rs Th1,833.8623.2 294.3%   
INCOME DATA
Net Sales Rs m290,659803,254 36.2%  
Other income Rs m10,2550-   
Total revenues Rs m300,914803,254 37.5%   
Gross profit Rs m63,076207,852 30.3%  
Depreciation Rs m17,533150,401 11.7%   
Interest Rs m5,55338,634 14.4%   
Profit before tax Rs m50,24618,818 267.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-12,1440-   
Tax Rs m6,009-2,994 -200.7%   
Profit after tax Rs m32,09321,812 147.1%  
Gross profit margin %21.725.9 83.9%  
Effective tax rate %12.0-15.9 -75.2%   
Net profit margin %11.02.7 406.6%  
BALANCE SHEET DATA
Current assets Rs m310,692448,537 69.3%   
Current liabilities Rs m173,396327,033 53.0%   
Net working cap to sales %47.215.1 312.3%  
Current ratio x1.81.4 130.6%  
Inventory Days Days9984 118.5%  
Debtors Days Days11293 119.6%  
Net fixed assets Rs m232,477155,818 149.2%   
Share capital Rs m2,399428 561.0%   
"Free" reserves Rs m411,6910-   
Net worth Rs m414,091868,974 47.7%   
Long term debt Rs m15,226937,902 1.6%   
Total assets Rs m646,9382,330,927 27.8%  
Interest coverage x10.01.5 675.8%   
Debt to equity ratio x01.1 3.4%  
Sales to assets ratio x0.40.3 130.4%   
Return on assets %5.82.6 224.4%  
Return on equity %7.82.5 308.8%  
Return on capital %10.23.2 319.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m27,4150-   
CASH FLOW
From Operations Rs m21,965166,916 13.2%  
From Investments Rs m-6,813-86,277 7.9%  
From Financial Activity Rs m-27,305-77,759 35.1%  
Net Cashflow Rs m-8,4421,383 -610.5%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.28 Rs / USD

Compare SUN PHARMA With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: STRIDES PHARMA SCIENCE  JUBILANT LIFE SCIENCES  FDC LTD.  NOVARTIS  TORRENT PHARMA  



Today's Market

Sensex Ends 226 Points Higher; Capital Goods and Banking Stocks Witness Buying(Closing)

Indian share markets ended their trading session on a positive note today. At the closing bell, the BSE Sensex stood higher by 226 points (up 0.6%).

Related Views On News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Bet on These Smallcap Stocks for Success in 2020 (Profit Hunter)

Jan 14, 2020

The smallcap rebound finally seems to here... Make sure you aren't too late to make the most of the biggest wealth making opportunity in a decade.

Guess Which Stocks Are Rising at Double the Speed of Sensex (Profit Hunter)

Jan 15, 2020

These stocks can move twice as fast as the Sensex - to take advantage of their money multiplying power get in now as the rally is still just taking shape.. read more to not miss out.

For 1,000%+ Gains, Follow the 8-Year Cycle in the Stock Market (Fast Profits Daily)

Jan 17, 2020

This is how the biggest trading profits are made.

What the Infosys Results Tell Us About the Next Infosys (The 5 Minute Wrapup)

Jan 15, 2020

If you're interested in the next Infosys, I'll tell you where to look.

How to Buy the Best Safe Stocks in 2020 (The 5 Minute Wrapup)

Jan 17, 2020

Don't fall for the safe stocks narrative going around in the stock market these days.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
A Simple Test to Find out If a Stock Has 100x Potential
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

SUN PHARMA SHARE PRICE


Jan 24, 2020 03:37 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA - ALEMBIC PHARMA COMPARISON

COMPARE SUN PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS